GR3006212T3 - - Google Patents

Info

Publication number
GR3006212T3
GR3006212T3 GR920402144T GR920402144T GR3006212T3 GR 3006212 T3 GR3006212 T3 GR 3006212T3 GR 920402144 T GR920402144 T GR 920402144T GR 920402144 T GR920402144 T GR 920402144T GR 3006212 T3 GR3006212 T3 GR 3006212T3
Authority
GR
Greece
Prior art keywords
peptides
polypeptides
cells
nonmammalian
inhibition
Prior art date
Application number
GR920402144T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006212T3 publication Critical patent/GR3006212T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GR920402144T 1986-06-04 1992-11-12 GR3006212T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87044086A 1986-06-04 1986-06-04

Publications (1)

Publication Number Publication Date
GR3006212T3 true GR3006212T3 (el) 1993-06-21

Family

ID=25355375

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402144T GR3006212T3 (el) 1986-06-04 1992-11-12

Country Status (9)

Country Link
EP (1) EP0248642B1 (el)
JP (1) JPS6322100A (el)
AT (1) ATE81591T1 (el)
AU (1) AU612575B2 (el)
CA (1) CA1320906C (el)
DE (1) DE3782276T2 (el)
ES (1) ES2052562T3 (el)
GR (1) GR3006212T3 (el)
IL (1) IL82734A (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
NZ766453A (en) 2018-02-01 2022-02-25 Nkmax Co Ltd Method of producing natural killer cells and composition for treating cancer

Also Published As

Publication number Publication date
IL82734A (en) 1992-05-25
EP0248642A2 (en) 1987-12-09
ATE81591T1 (de) 1992-11-15
DE3782276T2 (de) 1993-03-04
EP0248642A3 (en) 1989-11-02
ES2052562T3 (es) 1994-07-16
JPS6322100A (ja) 1988-01-29
CA1320906C (en) 1993-08-03
AU612575B2 (en) 1991-07-18
EP0248642B1 (en) 1992-10-21
IL82734A0 (en) 1987-12-20
AU7378087A (en) 1987-12-10
DE3782276D1 (de) 1992-11-26

Similar Documents

Publication Publication Date Title
PT82127A (en) Process for the preparation of phenyl carbamates
AU6733487A (en) Mammalian interleukin-4
IE862072L (en) Oxa- and azahomocyclostatine polypeptides and related¹intermediates
FI101720B1 (fi) Synteettisen DNA:n konstruointi ja sen käyttö suurten polypeptidien synteesissä
DE3750106T3 (de) Rekombinanter B-Zell-Differenzierungsfaktor.
PT85849A (en) Process for the preparation of novel lymphokine related peptides
GR80840B (en) Novel polypeptide with a - amylase inhibiting effect, method for the preparation thereof, use and pharmaceutical preparations thereof
AU572447B2 (en) Interferons via recombinant dna
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
ES8704511A1 (es) Procedimiento para sintetizar peptidos a partir de aminoaci-dos
JPS6485098A (en) Glycoprotein and production thereof
GR3006212T3 (el)
ES2002915A6 (es) Un procedimiento para la preparacion de un peptido de veneno de serpiente que detiene el crecimiento.
AU2684388A (en) Peptides acting to influence the mammalian pituitary
AU525042B2 (en) Ovulation enhancing peptides
AU583645B2 (en) Novel benzodioxepanne, process for the synthesis thereof and uses thereof in therapeutics